BIOVENTUS INC. - CLASS A COMMON STOCK
6.3800
06-May-25 13:22:50
15 minutes delayed
Stocks
-0.6500
-9.25%
Today's range
6.0200 - 7.0000
ISIN
N/A
Source
NASDAQ
-
Bioventus Reports First Quarter Financial Results
06 May 2025 06:30:00 By Nasdaq GlobeNewswire
-
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
28 Apr 2025 07:00:00 By Nasdaq GlobeNewswire
-
Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results
11 Mar 2025 06:30:01 By Nasdaq GlobeNewswire
-
Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025
28 Feb 2025 06:30:00 By Nasdaq GlobeNewswire
-
Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07 Jan 2025 07:00:01 By Nasdaq GlobeNewswire
-
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
02 Jan 2025 07:00:00 By Nasdaq GlobeNewswire
-
Bioventus Reports Third Quarter Financial Results
05 Nov 2024 06:30:00 By Nasdaq GlobeNewswire
-
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
29 Oct 2024 06:30:00 By Nasdaq GlobeNewswire
-
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
01 Oct 2024 08:00:01 By Nasdaq GlobeNewswire
-
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
07 Aug 2024 15:15:00 By Nasdaq GlobeNewswire
-
Bioventus Reports Second Quarter Financial Results
06 Aug 2024 06:30:00 By Nasdaq GlobeNewswire
-
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
30 Jul 2024 06:30:00 By Nasdaq GlobeNewswire
-
Bioventus Reports First Quarter Financial Results
07 May 2024 06:00:01 By Nasdaq GlobeNewswire
-
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
29 Apr 2024 06:30:00 By Nasdaq GlobeNewswire
-
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
12 Mar 2024 06:30:01 By Nasdaq GlobeNewswire
-
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
04 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
18 Jan 2024 15:15:00 By Nasdaq GlobeNewswire
-
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
12 Jan 2024 15:15:00 By Nasdaq GlobeNewswire
-
Bioventus Names Robert Claypoole as President and Chief Executive Officer
19 Dec 2023 15:30:00 By Nasdaq GlobeNewswire
-
06 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >